Colnot DR, et al. Cancer Immunol. Immunother. (2003) cited as Ref 554 in DOI: 10.1038/s41392-020-0110-5

From Wikibase.slis.ua.edu
Revision as of 15:09, 20 May 2020 by Maintenance script (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Bibliography entry in "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8; DOI: https://doi.org/10.1038/s41392-020-0110-5


Information about this Cited Reference
TitleSafety biodistribution pharmacokinetics and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
DOI10.1007/s00262-003-0396-5
1st AUColnot DR
PubDate2003
JournalCancer Immunol. Immunother.
Volume52
Page(s)576-582
Cited InTargeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5)
Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Colnot_DR,_et_al._Cancer_Immunol._Immunother._(2003)_cited_as_Ref_554_in_DOI:_10.1038/s41392-020-0110-5&oldid=198457"